Quanterix Corp

자세한 내용은 Quanterix Corp 회사

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

회사 정보

종목 코드 QTRX

회사 이름Quanterix Corp

상장일Dec 07, 2017

CEODr. Masoud Toloue, Ph.D.

직원 수471

유형Ordinary Share

회계 연도 종료Dec 07

주소900 Middlesex Turnpike

도시BILLERICA

증권 거래소NASDAQ Global Market Consolidated

국가United States of America

우편 번호01821

전화16173019400

웹사이트https://www.quanterix.com/

종목 코드 QTRX

상장일Dec 07, 2017

CEODr. Masoud Toloue, Ph.D.

회사 임원

이름

이름/직위

직위

주식 보유

변동

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.12%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

278.40K

-0.44%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

130.34K

+3.33%

Mr. Scott Mendel

Director

28.65K

--

Dr. Myla P. Lai-Goldman, M.D.

Director

27.40K

--

Ms. Karen A. Flynn

Independent Director

26.41K

+20.04%

Mr. Jeffrey Thomas (Jeff) Elliott

Independent Director

19.42K

+62.04%

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

9.28K

-2.41%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

--

Mr. Paul M. Meister

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.12%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

278.40K

-0.44%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

130.34K

+3.33%

Mr. Scott Mendel

Director

28.65K

--

Dr. Myla P. Lai-Goldman, M.D.

Director

27.40K

--

Ms. Karen A. Flynn

Independent Director

26.41K

+20.04%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

사업별USD

이름

수익

비율

Product revenue

20.74M

68.51%

Service and other revenue

8.76M

28.95%

Collaboration and license revenue

771.00K

2.55%

지역별USD

이름

수익

비율

North America

19.38M

64.01%

EMEA

6.63M

21.92%

Asia Pacific

4.26M

14.07%

사업별

지역별

사업별USD

이름

수익

비율

Product revenue

20.74M

68.51%

Service and other revenue

8.76M

28.95%

Collaboration and license revenue

771.00K

2.55%

주식 보유 통계

마지막 업데이트: Sat, Aug 2

주주

주주 유형

주주

비율

Columbia Threadneedle Investments (UK)

6.49%

Portolan Capital Management, L.L.C.

6.41%

BlackRock Institutional Trust Company, N.A.

5.81%

The Vanguard Group, Inc.

5.47%

Kent Lake PR LLC

4.52%

Other

71.29%

주주

비율

Columbia Threadneedle Investments (UK)

6.49%

Portolan Capital Management, L.L.C.

6.41%

BlackRock Institutional Trust Company, N.A.

5.81%

The Vanguard Group, Inc.

5.47%

Kent Lake PR LLC

4.52%

Other

71.29%

주주 유형

주주

비율

Investment Advisor/Hedge Fund

30.87%

Investment Advisor

25.39%

Hedge Fund

12.76%

Individual Investor

6.60%

Research Firm

3.49%

Pension Fund

0.35%

Bank and Trust

0.21%

Family Office

0.13%

Venture Capital

0.05%

Other

20.15%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

391

37.62M

83.70%

-11.91M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

2023Q2

388

36.74M

98.24%

-9.95M

2023Q1

389

37.25M

100.03%

-8.36M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Columbia Threadneedle Investments (UK)

3.00M

7.72%

+237.57K

+8.60%

Mar 31, 2025

Portolan Capital Management, L.L.C.

2.96M

7.63%

+375.57K

+14.51%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.68M

6.91%

-89.03K

-3.21%

Mar 31, 2025

The Vanguard Group, Inc.

2.53M

6.5%

+316.41K

+14.32%

Mar 31, 2025

Kent Lake PR LLC

2.92M

7.53%

+279.82K

+10.58%

Mar 31, 2025

Walt (David R)

1.86M

4.79%

+370.00K

+24.84%

Jun 13, 2025

William Blair Investment Management, LLC

1.11M

2.85%

+43.96K

+4.14%

Mar 31, 2025

UBS Financial Services, Inc.

1.11M

2.87%

+186.90K

+20.14%

Mar 31, 2025

Easterly Investment Partners LLC

1.33M

3.41%

+370.63K

+38.81%

Mar 31, 2025

Invenomic Capital Management LP

902.04K

2.32%

+546.67K

+153.83%

Mar 31, 2025

5.999USD

Quanterix Corp

5.999

개요

회사

금융